🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I’m honored to serve as the next CEO of the @osuccc_james & look forward to joining my new Buckeye colleagues at @osuwexmed & @ohiostate to take bold steps to advance the future of oncology across Ohio & nationally. Check out my LinkedIn to learn more. go.osu.edu/C4w3

A plug for our Alliance for Clinical Trials in Oncology trial for patients with BRCA1/2 or PALB2 mutant pancreas cancer! #NCTN #PancChat Eileen M O’Reilly Kim Reiss Binder (Kim Reiss) Mike Pishvaian Efrat Dotan MD Hagen Kennecke Anirban Maitra Sharlene Gill, MD, MPH, MBA, FASCO PanCAN BasserBRCA @FacingOurRisk

Congratulations to Memorial Sloan Kettering Cancer Center MSK-IMPACT team and OncoKB™ for receiving the #AACR25 TEAM Science Award! The impact of this team, assay & data to our understanding of cancer biology is unprecedented.

Join MSK thoracic medical oncologist Dr. Kathryn Arbour (Kathryn C. Arbour) for a plenary session titled “Preliminary safety and antitumor activity of zoldonrasib (RMC-9805), an oral, RAS(ON) G12D-selective, tri-complex inhibitor in patients with KRAS G12D non-small cell lung cancer

Among dMMR solid tumors, 82% had complete clinical response with PD-1 blockade. Utility of ctDNA dynamics shown.

In her plenary session at #AACR25, Andrea Cercek shared that PD-1 #immunotherapy can eliminate the need for surgery in patients with early-stage, DNA mismatch repair-deficient solid cancers. Learn more: bit.ly/3GvgqP2 AACR

#ASCO25 ASCO 4 weeks away and looks like it is going to be a practice-changing #ASCO25 for #GIcancers👍 👇my top picks for key abstracts to watch for🌟 ➡️Two GI plenary sessions🏅 MATTERHORN #STCsm Yelena Y. Janjigian MD ATOMIC #dMMR #CRCsm Frank Sinicrope, MD ➡️Clinical Science Symposium

Congrats to Mark G. Kris, Kenneth Offit, David G. Pfister, and Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 on being inducted into the 13th Giants of Cancer Care® class by OncLive.com! This award honors leading physicians who are advancing #cancerresearch. Memorial Sloan Kettering Cancer Center Learn more: bit.ly/42Ox58M

MSK is pleased to announce TIME has named two MSK physician-scientists, Andrea Cercek and Vinod BalachandranMD, to the 2025 TIME100 Health, a list of the 100 most influential individuals in health and medicine who have made significant contributions to improving global health outcomes,

🚨 THRILLED to welcome my friend and colleague Manuel Hidalgo 🇪🇸 🇺🇸 as the co-director of the new GI Cancer Center at Perlmutter Cancer Center at NYU Langone Health NYU Langone Health Manny & I collaborated for over a decade in #PancreaticCancer research at Hopkins, so I am delighted to get the band back together in NYC! 🗽

Congratulations to Will Freed Pastor Hale Family Center For Pancreatic Cancer Research on his foundational Science Magazine paper!! Totally transforms the landscape of #PancreaticCancer tumor antigens. Jacks Lab Break Through Cancer Lustgarten Foundation science.org/doi/10.1126/sc…

Innovation. Collaboration. Hope. Join us at KSMO2025 — the future of cancer care starts here. #KSMO25 youtube.com/shorts/Jvm6X4l…

A tour de force from Jessie Elliott on contemporary management, survivorship challenges and novel research approaches in upper gastrointestinal malignancies Trinity College Dublin Jessie Elliott Trinity St James's Cancer Institute Maeve Lowery

Congratulations to Dr. Mark Kris Memorial Sloan Kettering Cancer Center for being named a Giant of Cancer Care for his many contributions to advancing the field of thoracic oncology! OncLive.com #lcsm onclive.com/view/giants-of… via @onclive

🚨The FDA granted accelerated approval to avutometinib & defactinib for adults with KRAS-mutated recurrent low-grade serous #ovariancancer. Congrats to MSK's Rachel Grisham, Global Lead Principal Investigator of GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301! bit.ly/3ETZS2F

Combined #preprint and paper alert! Together with Sohrab Shah and Vivian E. Strong, MD, we have been exploring a fundamental paradox of cancer biology: how can the immune response both suppress and facilitate tumorigenesis? (It's a 2-parter!) biorxiv.org/content/10.110…

🔥EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma🔥 Journal of Hepatology doi.org/10.1016/j.jhep… 👉get the lastest update on the diagnosis and management of eCCA ESMO - Eur. Oncology EASL Education ILCA #livertwitter

Excited for all the amazing expert speakers in PER panels at ASCO: NSCLC,mBC,Glioma,PDAC,CRC,AML,MPN and MM at ASCO! Hope to see you all there! Benjamin Levy Christine Lovly, MD, PhD, FASCO Balazs Halmos Manmeet Ahluwalia, MD, MBA, FASCO Paolo Tarantino Eileen M O’Reilly Hagop Kantarjian,MD Percy Lee MD Naveen Pemmaraju, MD

Thank you Fordham Law Memorial Sloan Kettering Cancer Center MSK Department of Medicine for the opportunity!

Congratulations to all my current & new colleagues at MD Anderson Cancer Center (Benjamin Schrank, MD, PhD AND his former PhD mentor Jean Gautier). So happy to see Raghu Kalluri Kalluri Lab get funded for the 1st exosome biology and therapeutics core in the state of Texas! cprit.texas.gov/news-events/ar…